Artemis Therapeutics Inc.
Artemis Therapeutics Inc.（ATMS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ATMS · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
1
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Artemis Therapeutics Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ATMS 季度内部人买卖趋势
ATMS 内幕交易卖出 · ATMS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
ATMS 高管卖出股份 · ATMS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Dec 18, 2018 | Peleg Gadi Director | Sale | 182 | $47 | Form 4 |
| Oct 23, 2017 | Culley Brian M CEO | Purchase | 25,000 | $25K | Form 4 |
| Jun 26, 2017 | Wolf Dana Chief Scientific Officer | Option | 35,202 | $352 | Form 4 |
| Jan 25, 2012 | Gilat Tal President and CEO | Award | 2,055,604 | — | Form 4 |
| Mar 3, 2011 | Schoenheimer Pierre Lucien Director | Sale | 10,000 | $2K | Form 4 |
| Mar 2, 2011 | Peleg Gadi Chairman of the Board · Director | Award | 277,778 | $50K | Form 4 |
| Mar 2, 2011 | Raich Alon Director | Award | 62,500 | $11K | Form 4 |
| Mar 2, 2011 | Bettsak Jonathan Director | Award | 48,611 | $9K | Form 4 |
| Mar 2, 2011 | Schoenheimer Pierre Lucien Director | Award | 62,500 | $11K | Form 4 |
| Mar 2, 2011 | SASS DAVID W Secretary · Director | Award | 62,500 | $11K | Form 4 |
| Oct 15, 2010 | Schoenheimer Pierre Lucien Director | Sale | 45,000 | $7K | Form 4 |
| Oct 18, 2010 | Schoenheimer Pierre Lucien Director | Sale | 19,000 | $3K | Form 4 |
| Mar 11, 2010 | Peleg Gadi Chairman ot the Board · Director | Purchase | 1,600,000 | $200K | Form 4 |
| Mar 11, 2010 | Raich Alon Director | Purchase | 200,000 | $25K | Form 4 |
| Mar 11, 2010 | MEERFELD YARON COO · Director | Purchase | 800,000 | $100K | Form 4 |
| Mar 11, 2010 | Schoenheimer Pierre Lucien Director | Purchase | 2,000,000 | $250K | Form 4 |
| Mar 30, 2007 | Schoenheimer Pierre Lucien Director | Purchase | 25,000 | $48K | Form 4 |
| Mar 30, 2007 | ICTS INTERNATIONAL N V 10 percent owner | Sale | 155,000 | $295K | Form 4 |
| Dec 12, 2006 | HOUSMAN ELIE Chairman and CEO · Director | Gift | 7,000 | — | Form 4 |
Peleg Gadi
Chairman ot the Board · Director
日期
Mar 11
股数
1,600,000
均价
$0.13
总金额
$200K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ATMS 内幕交易
ATMS 内幕交易
Artemis Therapeutics Inc.（ATMS）内幕交易数据来源于公司内部人（包括ATMS）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。ATMS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Artemis Therapeutics Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ATMS 内幕交易 · 5个问题Artemis Therapeutics Inc.（ATMS）的内部人包括高管和董事，如ATMS等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026